Evidence map›Paper›PMID 21167057›Full record

ArticleBreast cancer research : BCR2010

Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway.

Lulu Mao, Lin Yuan, Lauren M Slakey, Frank E Jones, Matthew E Burow, Steven M Hill

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 161 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Melatonin, an Antitumor Necrosis Factor Therapy.Journal of pineal research · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. P38 kinase in gastrointestinal cancers.Cancer gene therapy · 2023
    Review
  11. Review
  12. Article
  13. Vivarium Lighting as an Important Extrinsic Factor Influencing Animal-based Research.Journal of the American Association for Laboratory Animal Science : JAALAS · 2023
    Review
  14. Review
  15. Review
  16. Protective Role of Melatonin and Its Metabolites in Skin Aging.International journal of molecular sciences · 2022
    Review
  17. Review
  18. Melatonin MTAmerican journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  19. Article
  20. Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lulu MaoDepartment of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA. lmao1@tulane.edu
Lin Yuan
Lauren M Slakey
Frank E Jones
Matthew E Burow
Steven M Hill
Tulane University · US

Funding

NEUROENDOCRINE INFLUENCES ON MAMMARY CANCERR01CA054152 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI HILL, STEVEN M · 1997 to 2007
$2.0M
NCI NIH HHS 5R01 CA 54152-14
6 · The paper itself

Abstract

introductionThe pineal gland hormone, melatonin, has been shown by numerous studies to inhibit the proliferation of estrogen receptor α (ERα)-positive breast cancer cell lines. Here, we investigated the role of melatonin in the regulation of breast cancer cell invasion.

methodsThree invasive MCF-7 breast cancer cell clones - MCF-7/6, MCF-7/Her2.1, and MCF-7/CXCR4 cells - were employed in these studies. All three cell lines exhibited elevated phosphorylation of the ERK1/2 and p38 mitogen-activated protein kinase (MAPK) as determined by Western blot analysis. The effect of melatonin on the invasive potential of these human breast cancer cells was examined by matrigel invasion chamber assays. The expression and proteinase activity of two matrix metalloproteinases (MMPs), MMP-2 and MMP-9, were analyzed by Western blot analysis and gelatin zymography, respectively.

resultsMelatonin (10-9 M) significantly suppressed the invasive potential of MCF-7/6 and MCF-7/Her2.1 cells as measured by matrigel invasion chamber assays, and significantly repressed the proteinase activity of MMP-2 and MMP-9. In MCF-7/CXCR4 cells, melatonin significantly inhibited stromal-derived factor-1 (SDF-1/CXCL12) induced cell invasion and activity of MMP-9. Elevated expression of the MT1 melatonin receptor further enhanced, while luzindole, an MT1/MT2 antagonist, abrogated melatonin's anti-invasive effect, suggesting that melatonin's effect on invasion is mediated, principally, through the MT1 receptor. Furthermore, melatonin repressed the phosphorylation of p38 MAPK in MCF-7/Her2.1 cells and blocked stromal-derived factor-1 (SDF-1) induced p38 phosphorylation in MCF-7/CXCR4 cells. SB230580, a p38 inhibitor, was able to mimic, while transfection of the cells with a constitutively-active MKK6b construct blocked melatonin's effect on cell invasion, suggesting that the anti-invasive action of melatonin is mediated through the p38 pathway.

conclusionsMelatonin exerts an inhibitory effect on breast cancer cell invasion through down-regulation of the p38 pathway, and inhibition of MMP-2 and MMP-9 expression and activity.

Indexed as

Blotting, WesternBreast NeoplasmsCell Line, TumorChemokine CXCL12FemaleGene ExpressionHumansMAP Kinase Signaling SystemMatrix MetalloproteinasesMelatoninNeoplasm Invasivenessp38 Mitogen-Activated Protein KinasesPhosphorylationReceptor, Melatonin, MT1Reverse Transcriptase Polymerase Chain ReactionTryptaminesChemokine CXCL12luzindoleMatrix MetalloproteinasesMelatoninp38 Mitogen-Activated Protein KinasesReceptor, Melatonin, MT1Tryptamines

Identifiers

PMID21167057
PMCPMC3046452
OpenAlexW2131239750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.